Godavari Drugs Limited reported earnings results for the third quarter and nine months ended December 31, 2021. For the third quarter, the company reported sales was INR 337.57 million compared to INR 330.99 million a year ago. Revenue was INR 338.1 million compared to INR 331.81 million a year ago. Net income was INR 13.32 million compared to INR 10.03 million a year ago. Basic earnings per share from continuing operations was INR 1.77 compared to INR 1.33 a year ago. Diluted earnings per share from continuing operations was INR 1.77 compared to INR 1.33 a year ago.
For the nine months, sales was INR 1,168.26 million compared to INR 897.12 million a year ago. Revenue was INR 1,169.86 million compared to INR 900.08 million a year ago. Net income was INR 39.78 million compared to INR 28.42 million a year ago. Basic earnings per share from continuing operations was INR 5.28 compared to INR 3.77 a year ago. Diluted earnings per share from continuing operations was INR 5.28 compared to INR 3.77 a year ago.